Andrew Conrad

Investor

General Partner at S32

About

General Partner of S32 and founder and former CEO/Executive Chairman of Verily, Alphabet's healthcare company. Previously CSO of LabCorp and co-founder of the National Genetics Institute; holds a PhD in cell biology from UCLA.

Deals · 2

MedcryptBoard seat

via S32 · filed Feb 2025 · $8.7M raise

Alpha SourceBoard seat

via S32 · filed Nov 2022 · $25.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at S32

Ainhoa Maiz

Principal at S32

Alice Cheung

Partner, Talent at S32

Allison Pavlick

Investor Relations Principal at S32

Andy Harrison

General Partner, CEO at S32

Ayesha Arora

Venture Partner at S32

Bayan Alizadeh

Partner at S32

Bill Maris

General Partner, Founder at S32

Carlos Solórzano

Principal at S32